MD Anderson received $14 million in CPRIT research funding to recruit top talent
On Feb. 17, 2016, MD Anderson Cancer Center was awarded $14 million from the Cancer Prevention and Research…
-
-
CPRIT awarded $26 million in grants to support its academic research program
On Feb. 17, 2016, the Cancer Prevention and Research Institute of Texas (CPRIT) awarded grants totaling $26,000,000 to…
-
Artificial Intelligence | Biotechnology | CRISPR | Genomics | Medicine | NIH | Non-Profit Research | Oncology | Therapeutics | Vaccine
The Cancer MoonShot Project was announced
On Jan. 12, 2016, a consortium of industry, government, and academia announced the launch of the Cancer MoonShot…
-
TapImmune announced it’s corporate headquarters relocation from Seattle to Jacksonville Florida
On Nov. 5, 2015, TapImmune, (TPIV) announced it had relocated its corporate headquarters from Seattle, Washington, to Jacksonville,…
-
Calgary cancer centre to be built at northeast corner of Foothills hospital site
On Oct. 28, 2015, it was announced that Calgary’s new cancer centre will be built at the northeast…
-
The Omar Boraie Chair in Genomic Science was established at Rutgers Cancer Institute
On Oct. 21, 2015, the Omar Boraie Chair in Genomic Science was established at Rutgers Cancer Institute. The…
-
Southwestern lung cancer researcher Dr John Minna named Giant of Cancer Care
On Oct. 6, 2015, Cancer biologist Dr. John Minna, with the Harold C. Simmons Comprehensive Cancer Center at…
-
The University of New Mexico Cancer Center received National Cancer Institute designation
On Aug. 12. 2015, the University of New Mexico Cancer Center received National Cancer Institute (NCI) designation. Cancer…
-
Biotechnology | Diagnostics | Disease | NIH | Non-Profit Research | Oncology | Radiology | Therapeutics
The Harold C Simmons Cancer Center received The National Cancer Institute designation
On Jul. 10, 2015, the National Cancer Institute (NCI) announced it had awarded the UT Southwestern Medical Center’s…
-
CDC published ACIP recommendations for use of 9-valent HPV vaccine
On Mar. 27, 2015, the U.S. Centers for Disease Control and Prevention (CDC) recommended 9-valent human papillomavirus (HPV)…
-
Sylvester Comprehensive Cancer Center was designated a Cancer Center of Excellence by the State of Florida
On Mar. 25, 2015, the Sylvester Comprehensive Cancer Center was designated a Cancer Center of Excellence by the…
-
Dendreon was acquired by Valeant Pharmaceuticals for $495 million
On Feb. 23, 2015, a bankruptcy judge approved the sale of the assets of Dendreon Corp., a Seattle-based…
-
The Human Vaccines Project was launched
On Feb. 17, 2015, the International AIDS Vaccine Initiative (IAVI) announced it had received a grant of US…
-
FDA approved the use of Gardasil 9 HPV vaccine in the US
On Dec. 11, 2014, Merck announced that the FDA had approved GARDASILﾮ9 (Human Papillomavirus 9-valent Vaccine, Recombinant), Merckﾒs…
-
The North Carolina Eshelman School of Pharmacy received $100 million donation from Fred Eshelman
On Dec. 3, 2014, Fred Eshelman, CEO and founder of Wilmington-based PPD Inc. and a member of the…
-
The Fred & Pamela Buffett Cancer Center announced recruitment of five leading cancer researchers
On Dec. 3, 2014, the Fred & Pamela Buffett Cancer Center at the University of Nebraska Medical Center…
-
Ford Family Foundation awarded $5 million grant to advance the OHSU Knight Cancer Institute’s rural outreach
On Nov. 5, 2014, the Ford Family Foundation announced a $5 million grant to the Knight Cancer Institute…
-
Mary-Claire King received Lasker Foundation Award
On Sept. 8, 2014, the University of Washington and UW Medicine announced that Mary-Claire King, UW professor of…
-
Biotechnology | Chemistry | FDA | Oncology | Therapeutics | Women's Health
FDA approved Genentech’s Avastin plus chemotherapy for treatment of advanced cervical cancer
On Aug. 14. 2014, Genentech announced that the U.S. Food and Drug Administration (FDA) had approved Avastin (bevacizumab)…
-
Bezos family donated $20 million to the Fred Hutch to develop therapies that ‘melt’ cancer
On Apr. 7, 2014, the Fred Hutchinson Cancer Research Center announced that the Bezos family had committed $20…
-
Biotechnology | CDC | Influenza | Non-Profit Research | Radiology | Stem Cell | Vaccine
CDC published ACIP recommendations for prevention and control ofﾠ Haemophilus influenzaeﾠ type b (Hib) ﾠdisease
On Feb. 28, 2014, the U.S. Centers for Disease Control and Prevention (CDC) published Immunization Practices Advisory Committee…
-
Laura and Isaac Perlmutter donated $50 million to advance cancer research and treatment at NYU Langone Medical Center
On Jan. 29, 2014, NYU Langone Medical Center announced it had received an initial gift in excess of…
-
Siteman Cancer Center debuted the first single-vault proton therapy center in the country
On Dec. 19, 2013, the Siteman Cancer Center debuted the first single-vault proton therapy center in the U.S.:…
-
Juno Theraputics was founded
On Dec. 3, 2013, Juno Theraputics, a biotechnology company focused on bringing forward novel immunotherapies for cancer, was…
-
Researchers at the Princess Margaret Hospital in Toronto halted cancer growth by targeting cancer stem cells
On Dec. 1, 2013, researchers at the Princess Margaret Hospital in Toronto, led by Dr. John Dick, announced…
-
Karmanos Cancer Institute joined McLaren Health Care
On Oct. 30, 2013, the Karmanos Cancer Institute and McLaren Health Care signed an agreement that created the…
-
Biotechnology | Diagnostics | Non-Profit Research | Oncology | Pharmaceutical | Radiology | Therapeutics
UNMC Renamed Eppley Cancer Center to the Fred & Pamela Buffett Cancer Center
In Jun. 7, 2013, the University of Nebraska Board of Regents approved changing the name of the UNMC…
-
Biotechnology | CDC | Oncology | Therapeutics
Report to the nation finds continuing declines in cancer death rates since the early 1990s
On Mar. 29, 2012, the U.S. Centers for Disease Control and Prevention (CDC) reported that death rates from…
-
Duke Cancer Institute opened the Duke Cancer Center, a new 7-floor building
On Feb. 27, 2012, the Duke Cancer Institute opened a new 267,000-square-foot, $235 million Cancer Center that included…
-
Biotechnology | FDA | Oncology | Therapeutics
The U.S. FDA approved Erivedge (vismodegib) capsule, the first medicine for adults with advanced basal cell carcinoma
On Jan. 30, 2012, the U.S. Food and Drug Administration (FDA) approved Genentech’s Erivedge (vismodegib) capsule, the first…
